106 related articles for article (PubMed ID: 38713611)
1. Randomized clinical trial on D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in patients undergoing gastrectomy for cancer (DCGC01 study).
Xie D; Shen J; Liu L; Cao B; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Gong J
Br J Surg; 2024 May; 111(5):. PubMed ID: 38713611
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
3. [Short-term efficacy evaluation of laparoscopic spleen-preserving splenic hilus lymphadenectomy and left epigastrium mesogastric excision for advanced proximal gastric cancer based on mesangial anatomy].
Zhang YF; Chen P; Sun JG; Fan XJ; Wang YM; Gao YS
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):177-182. PubMed ID: 32074799
[No Abstract] [Full Text] [Related]
4. Complete mesogastric excision for locally advanced gastric cancer: short-term outcomes of a randomized clinical trial.
Xie D; Shen J; Liu L; Cao B; Wang Y; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Gong J
Cell Rep Med; 2021 Mar; 2(3):100217. PubMed ID: 33763656
[TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
[TBL] [Abstract][Full Text] [Related]
6. Long-term oncologic outcomes of a randomized controlled trial comparing laparoscopic versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer.
Shi Y; Xu X; Zhao Y; Qian F; Tang B; Hao Y; Luo H; Chen J; Yu P
Surgery; 2019 Jun; 165(6):1211-1216. PubMed ID: 30772006
[TBL] [Abstract][Full Text] [Related]
7. An Optimal Surgical Approach for Suprapancreatic Area Dissection in Laparoscopic D2 Gastrectomy with Complete Mesogastric Excision.
Cao B; Xiao A; Shen J; Xie D; Gong J
J Gastrointest Surg; 2020 Apr; 24(4):916-917. PubMed ID: 31898108
[TBL] [Abstract][Full Text] [Related]
8. Detection of carcinoembryonic antigen in peritoneal fluid of patients undergoing laparoscopic distal gastrectomy with complete mesogastric excision.
Xie D; Wang Y; Shen J; Hu J; Yin P; Gong J
Br J Surg; 2018 Oct; 105(11):1471-1479. PubMed ID: 29964324
[TBL] [Abstract][Full Text] [Related]
9. The short- and long-term outcomes of laparoscopic D2 lymphadenectomy plus complete mesogastrium excision for lymph node-negative gastric cancer.
Cai Z; Lin H; Li Z; Zhou J; Chen W; Liu F; Zhao H; Xu Y
Surg Endosc; 2024 Feb; 38(2):1059-1068. PubMed ID: 38082018
[TBL] [Abstract][Full Text] [Related]
10. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.
Sasako M; Sano T; Yamamoto S; Kurokawa Y; Nashimoto A; Kurita A; Hiratsuka M; Tsujinaka T; Kinoshita T; Arai K; Yamamura Y; Okajima K;
N Engl J Med; 2008 Jul; 359(5):453-62. PubMed ID: 18669424
[TBL] [Abstract][Full Text] [Related]
11. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial.
Hu Y; Huang C; Sun Y; Su X; Cao H; Hu J; Xue Y; Suo J; Tao K; He X; Wei H; Ying M; Hu W; Du X; Chen P; Liu H; Zheng C; Liu F; Yu J; Li Z; Zhao G; Chen X; Wang K; Li P; Xing J; Li G
J Clin Oncol; 2016 Apr; 34(12):1350-7. PubMed ID: 26903580
[TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial.
Chen QY; Xie JW; Zhong Q; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng HL; Li P; Zheng CH; Huang CM
JAMA Surg; 2020 Apr; 155(4):300-311. PubMed ID: 32101269
[TBL] [Abstract][Full Text] [Related]
13. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial.
Hyung WJ; Yang HK; Park YK; Lee HJ; An JY; Kim W; Kim HI; Kim HH; Ryu SW; Hur H; Kim MC; Kong SH; Cho GS; Kim JJ; Park DJ; Ryu KW; Kim YW; Kim JW; Lee JH; Han SU;
J Clin Oncol; 2020 Oct; 38(28):3304-3313. PubMed ID: 32816629
[TBL] [Abstract][Full Text] [Related]
15. Optimal extent of lymphadenectomy for gastric adenocarcinoma: A 7-institution study of the U.S. gastric cancer collaborative.
Randle RW; Swords DS; Levine EA; Fino NF; Squires MH; Poultsides G; Fields RC; Bloomston M; Weber SM; Pawlik TM; Jin LX; Spolverato G; Schmidt C; Worhunsky D; Cho CS; Maithel SK; Votanopoulos KI
J Surg Oncol; 2016 Jun; 113(7):750-5. PubMed ID: 26996496
[TBL] [Abstract][Full Text] [Related]
16. Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis.
Galizia G; Lieto E; De Vita F; Castellano P; Ferraraccio F; Zamboli A; Mabilia A; Auricchio A; De Sena G; De Stefano L; Cardella F; Barbarisi A; Orditura M
Surgery; 2015 Feb; 157(2):285-96. PubMed ID: 25532433
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer.
Cai J; Wei D; Gao CF; Zhang CS; Zhang H; Zhao T
Dig Surg; 2011; 28(5-6):331-7. PubMed ID: 21934308
[TBL] [Abstract][Full Text] [Related]
18. Short-term outcomes of D2 lymphadenectomy plus complete mesogastric excision for gastric cancer: a propensity score matching analysis.
Zhao D; Deng J; Cao B; Shen J; Liu L; Xiao A; Yin P; Xie D; Gong J
Surg Endosc; 2022 Aug; 36(8):5921-5929. PubMed ID: 35641697
[TBL] [Abstract][Full Text] [Related]
19. D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial.
Degiuli M; Reddavid R; Tomatis M; Ponti A; Morino M; Sasako M;
Eur J Cancer; 2021 Jun; 150():10-22. PubMed ID: 33887514
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]